{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2019 sorted by posted_date descending", "rows": [["FDA-2011-N-0902-0014", "FDA", "FDA-2011-N-0902", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:53:14Z", "2019-28249", 0, 0, "090000648425db88"], ["FDA-2018-N-4839-0003", "FDA", "FDA-2018-N-4839", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:56:25Z", "2019-28249", 0, 0, "090000648425d8b1"], ["FDA-2013-N-0662-0009", "FDA", "FDA-2013-N-0662", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:53:40Z", "2019-28249", 0, 0, "090000648425db89"], ["FDA-2019-N-5955-0001", "FDA", "FDA-2019-N-5955", "International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AB-FUBINACA; 5FAMB- PINACA; 5F-MDMB-PICA; 4-FMDMB- BINACA; 4-CMC; Nethylhexedrone; alpha-PHP; DOC; Crotonyl Fentanyl; Valeryl Fentanyl; Flualprazolam and Etizolam; Request for Comments", "Notice", "Request for Comments", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", "2020-01-31T04:59:59Z", "2020-02-01T02:02:04Z", "2019-28269", 0, 0, "090000648425d40c"], ["FDA-2019-P-3877-0003", "FDA", "FDA-2019-P-3877", "Determination That GLUCOPHAGE (Metformin Hydrochloride) Oral Tablets, 500 Milligrams, 850 Milligrams, and 1 Gram, and GLUCOPHAGE XR (Metformin Hydrochloride) Oral Extended-Release Tablets, 500 Milligrams and 750 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:31:28Z", "2019-28270", 0, 0, "090000648425d320"], ["FDA-2019-N-0549-0011", "FDA", "FDA-2019-N-0549", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:54:45Z", "2019-28249", 0, 0, "090000648425d866"], ["FDA-2016-N-3586-0005", "FDA", "FDA-2016-N-3586", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups About Drug Products as Used by the Food and Drug Administration", "Notice", "30 Day Proposed Information Collection", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", "2020-01-31T04:59:59Z", "2019-12-31T14:36:48Z", "2019-28247", 0, 0, "090000648425d323"], ["FDA-2013-N-0134-0149", "FDA", "FDA-2013-N-0134", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:47:33Z", "2019-28249", 0, 0, "090000648425d409"], ["FDA-2013-N-0242-0015", "FDA", "FDA-2013-N-0242", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:54:02Z", "2019-28249", 0, 0, "090000648425db8d"], ["FDA-2019-N-1517-0005", "FDA", "FDA-2019-N-1517", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:54:26Z", "2019-28249", 0, 0, "090000648425d865"], ["FDA-2012-N-0477-0011", "FDA", "FDA-2012-N-0477", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:55:36Z", "2019-28249", 0, 0, "090000648425d86a"], ["FDA-2016-D-2565-0018", "FDA", "FDA-2016-D-2565", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2019-12-31T14:56:03Z", "2019-28249", 0, 0, "090000648425d8ae"], ["FDA-2016-N-4319-0004", "FDA", "FDA-2016-N-4319", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Unique Device Identification System", "Notice", "General Notice", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", "2020-01-31T04:59:59Z", "2020-01-20T02:01:08Z", "2019-28246", 0, 0, "090000648425d412"], ["FDA-2019-N-0305-0005", "FDA", "FDA-2019-N-0305", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals", "Notice", "Notice of Approval", "2019-12-31T05:00:00Z", 2019, 12, "2019-12-31T05:00:00Z", null, "2022-10-14T13:05:41Z", "2019-28249", 0, 0, "090000648425d867"], ["FDA-2019-D-5743-0003", "FDA", "FDA-2019-D-5743", "Importation of Certain Food and Drug Administration-Approved Human\nPrescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for\nIndustry; Availability; Correction", "Notice", "Correction", "2019-12-30T05:00:00Z", 2019, 12, "2019-12-30T05:00:00Z", "2020-02-22T04:59:59Z", "2020-02-22T02:01:09Z", "2019-28141", 0, 0, "0900006484256d94"], ["FDA-2013-N-0804-0007", "FDA", "FDA-2013-N-0804", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notification", "Notice", "60 Day Proposed Information Collection", "2019-12-30T05:00:00Z", 2019, 12, "2019-12-30T05:00:00Z", "2020-02-29T04:59:59Z", "2019-12-30T15:11:07Z", "2019-28098", 0, 0, "0900006484256f92"], ["FDA-2019-D-5364-0001", "FDA", "FDA-2019-D-5364", "Submission of Plans for Cigarette Packages and Cigarette Advertisements; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-30T05:00:00Z", 2019, 12, "2019-12-30T05:00:00Z", "2020-01-30T04:59:59Z", "2020-01-30T02:03:13Z", "2019-27991", 0, 0, "0900006484256cad"], ["FDA-2018-N-2434-0003", "FDA", "FDA-2018-N-2434", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Formal Meetings\nBetween the Food and Drug Administration and Sponsors and Applicants of Prescription Drug User Fee Act Products", "Notice", "30 Day Proposed Information Collection", "2019-12-27T05:00:00Z", 2019, 12, "2019-12-27T05:00:00Z", "2020-01-28T04:59:59Z", "2019-12-27T15:31:52Z", "2019-27835", 0, 0, "090000648425244e"], ["FDA-2019-N-0001-0009", "FDA", "FDA-2019-N-0001", "The Tobacco Products Scientific Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2019-12-26T05:00:00Z", 2019, 12, "2019-12-26T05:00:00Z", null, "2019-12-26T14:49:56Z", "2019-27774", 0, 0, "090000648424fff4"], ["FDA-2013-N-0579-0009", "FDA", "FDA-2013-N-0579", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Biological\nProducts: Reporting of Biological Product Deviations and Human Cells,\nTissues, and Cellular and Tissue-Based Deviations in Manufacturing", "Notice", "30 Day Proposed Information Collection", "2019-12-26T05:00:00Z", 2019, 12, "2019-12-26T05:00:00Z", "2020-01-28T04:59:59Z", "2019-12-26T15:03:34Z", "2019-27791", 0, 0, "090000648424ffef"], ["FDA-2019-D-4739-0001", "FDA", "FDA-2019-D-4739", "Requesting Food and Drug Administration Feedback on Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2019-12-26T05:00:00Z", 2019, 12, "2019-12-26T05:00:00Z", "2020-02-25T04:59:59Z", "2020-02-25T02:01:52Z", "2019-27799", 0, 0, "090000648424ff26"], ["FDA-2019-D-5743-0001", "FDA", "FDA-2019-D-5743", "Importation of Certain Food and Drug Administration-Approved Human\nPrescription Drugs, Including Biological Products, Under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2019-12-23T05:00:00Z", 2019, 12, "2019-12-23T05:00:00Z", "2020-02-22T04:59:59Z", "2020-02-22T02:00:34Z", "2019-27475", 0, 0, "0900006484248282"], ["FDA-2018-D-3759-0011", "FDA", "FDA-2018-D-3759", "Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-20T05:00:00Z", 2019, 12, "2019-12-20T05:00:00Z", null, "2019-12-20T13:50:21Z", "2019-27520", 0, 0, "090000648423ff4d"], ["FDA-2019-D-4964-0001", "FDA", "FDA-2019-D-4964", "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-20T05:00:00Z", 2019, 12, "2019-12-20T05:00:00Z", "2020-02-19T04:59:59Z", "2020-02-23T17:58:48Z", "2019-27524", 0, 0, "090000648423ffd2"], ["FDA-2013-N-0403-0008", "FDA", "FDA-2013-N-0403", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Protection of Human Subjects; Informed Consent; and Institutional Review Boards", "Notice", "30 Day Proposed Information Collection", "2019-12-19T05:00:00Z", 2019, 12, "2019-12-19T05:00:00Z", "2020-01-22T04:59:59Z", "2019-12-19T14:57:36Z", "2019-27351", 0, 0, "0900006484235d08"], ["FDA-2019-D-5585-0001", "FDA", "FDA-2019-D-5585", "Bridging for Drug-Device and Biologic- Device Combination Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-19T05:00:00Z", 2019, 12, "2019-12-19T05:00:00Z", "2020-02-19T04:59:59Z", "2020-02-21T13:51:04Z", "2019-27354", 0, 0, "0900006484235c2e"], ["FDA-2010-D-0529-0023", "FDA", "FDA-2010-D-0529", "Qualification Process for Drug Development Tools; Draft Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2019-12-16T05:00:00Z", 2019, 12, "2019-12-16T05:00:00Z", "2020-02-15T04:59:59Z", "2020-02-15T02:02:17Z", "2019-26994", 0, 0, "0900006484212725"], ["FDA-2007-D-0369-0478", "FDA", "FDA-2007-D-0369", "Product-Specific Guidance for Cocaine Hydrochloride; Nasal Solution; New Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-16T05:00:00Z", 2019, 12, "2019-12-16T05:00:00Z", "2020-02-15T04:59:59Z", "2020-02-13T03:46:02Z", "2019-26971", 0, 0, "0900006484212850"], ["FDA-2018-N-1262-0008", "FDA", "FDA-2018-N-1262", "Notice of Approval of Product Under Voucher: Rare Pediatric Disease\nPriority Review Voucher", "Notice", "Notice of Approval", "2019-12-16T05:00:00Z", 2019, 12, "2019-12-16T05:00:00Z", null, "2019-12-16T15:12:52Z", "2019-27054", 0, 0, "0900006484212720"], ["FDA-2019-N-0001-0008", "FDA", "FDA-2019-N-0001", "Statement of Organization, Functions, and Delegations of Authority", "Notice", "General Notice", "2019-12-16T05:00:00Z", 2019, 12, "2019-12-16T05:00:00Z", null, "2019-12-16T18:09:47Z", "2019-26952", 0, 0, "090000648421284e"], ["FDA-2019-N-3077-0004", "FDA", "FDA-2019-N-3077", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities", "Notice", "30 Day Proposed Information Collection", "2019-12-16T05:00:00Z", 2019, 12, "2019-12-16T05:00:00Z", "2020-01-16T04:59:59Z", "2020-01-16T02:02:46Z", "2019-27053", 0, 0, "090000648421280b"], ["FDA-2019-D-4751-0001", "FDA", "FDA-2019-D-4751", "Food and Drug Administration Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-13T05:00:00Z", 2019, 12, "2019-12-13T05:00:00Z", "2020-02-12T04:59:59Z", "2020-05-06T20:45:01Z", "2019-26877", 0, 0, "090000648420c58d"], ["FDA-2016-E-2528-0007", "FDA", "FDA-2016-E-2528", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; BRIVIACT ORAL TABLETS, New Drug Application 205836", "Notice", "Determinations", "2019-12-12T05:00:00Z", 2019, 12, "2019-12-12T05:00:00Z", "2020-02-11T04:59:59Z", "2019-12-12T14:29:37Z", "2019-26813", 0, 0, "0900006484206ad6"], ["FDA-2018-N-0417-0002", "FDA", "FDA-2018-N-0417", "Request for Nominations on the National Mammography Quality Assurance Advisory Committee", "Notice", "Request for Nominations", "2019-12-12T05:00:00Z", 2019, 12, "2019-12-12T05:00:00Z", null, "2019-12-12T14:33:45Z", "2019-26735", 0, 0, "0900006484206b20"], ["FDA-2016-E-2529-0008", "FDA", "FDA-2016-E-2529", "Determination of Regulatory Review Period for Purposes of Patent Extension; BRIVIACT ORAL SOLUTION, New Drug Application 205838", "Notice", "Determinations", "2019-12-12T05:00:00Z", 2019, 12, "2019-12-12T05:00:00Z", "2020-02-11T04:59:59Z", "2019-12-12T14:38:30Z", "2019-26814", 0, 0, "0900006484206b7a"], ["FDA-2016-E-2525-0006", "FDA", "FDA-2016-E-2525", "Determination of Regulatory Review Period for Purposes of Patent Extension; BRIVIACT INJECTION New Drug Application 205837", "Notice", "Determinations", "2019-12-12T05:00:00Z", 2019, 12, "2019-12-12T05:00:00Z", "2020-02-11T04:59:59Z", "2020-01-28T02:04:02Z", "2019-26812", 0, 0, "0900006484206a35"], ["FDA-2016-N-2474-0005", "FDA", "FDA-2016-N-2474", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Reporting\nAssociated With Designated New Animal Drugs for Minor Use and Minor\nSpeciess", "Notice", "30 Day Proposed Information Collection", "2019-12-11T05:00:00Z", 2019, 12, "2019-12-11T05:00:00Z", "2020-01-11T04:59:59Z", "2023-06-02T20:19:47Z", "2019-26682", 0, 0, "0900006484200c94"], ["FDA-2018-E-2617-0003", "FDA", "FDA-2018-E-2617", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; VABOMERE", "Notice", "Determinations", "2019-12-11T05:00:00Z", 2019, 12, "2019-12-11T05:00:00Z", "2020-02-11T04:59:59Z", "2019-12-12T14:42:41Z", "2019-26655", 0, 0, "0900006484200d32"], ["FDA-2019-D-4433-0001", "FDA", "FDA-2019-D-4433", "Development of Locally Applied Corticosteroid Products for the Short- Term Treatment of Symptoms Associated With Internal or External Hemorrhoids; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-09T05:00:00Z", 2019, 12, "2019-12-09T05:00:00Z", "2020-02-08T04:59:59Z", "2020-02-08T02:03:51Z", "2019-26464", 0, 0, "09000064841f6201"], ["FDA-2019-D-1650-0001", "FDA", "FDA-2019-D-1650", "Magnetic Resonance Coil\u2014 Performance Criteria for Safety and Performance Based Pathway; Draft Guidance for Industry and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2019-12-09T05:00:00Z", 2019, 12, "2019-12-09T05:00:00Z", "2020-02-08T04:59:59Z", "2020-02-08T02:02:12Z", "2019-26470", 0, 0, "09000064841f62ee"], ["FDA-2019-E-1079-0005", "FDA", "FDA-2019-E-1079", "Determination of Regulatory Review Period for Purposes of Patent Extension: PALYNZIQ", "Notice", "Determinations", "2019-12-06T05:00:00Z", 2019, 12, "2019-12-06T05:00:00Z", "2020-06-04T03:59:59Z", "2019-12-06T14:26:16Z", "2019-26327", 0, 0, "09000064841ed900"], ["FDA-2019-N-5611-0001", "FDA", "FDA-2019-N-5611", "Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Meeting", "2019-12-06T05:00:00Z", 2019, 12, "2019-12-06T05:00:00Z", "2020-01-15T04:59:59Z", "2020-01-15T02:03:43Z", "2019-26377", 0, 0, "09000064841ed518"], ["FDA-2019-N-5552-0001", "FDA", "FDA-2019-N-5552", "Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request  for Comments", "Notice", "Meeting", "2019-12-06T05:00:00Z", 2019, 12, "2019-12-06T05:00:00Z", "2020-01-14T04:59:59Z", "2020-01-15T02:03:05Z", "2019-26338", 0, 0, "09000064841ecfa8"], ["FDA-2019-E-1076-0005", "FDA", "FDA-2019-E-1076", "Determination of Regulatory Review Period for Purposes of Patent Extension: PALYNZIQ", "Notice", "Determinations", "2019-12-06T05:00:00Z", 2019, 12, "2019-12-06T05:00:00Z", "2020-06-04T03:59:59Z", "2019-12-06T14:19:08Z", "2019-26327", 0, 0, "09000064841ed563"], ["FDA-2013-N-0731-0009", "FDA", "FDA-2013-N-0731", "Agency Information Collection Activities; Proposed Collection; Comment Request; Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Eligibility Determination for Donors; and Current Good Tissue Practice", "Notice", "60 Day Proposed Information Collection", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-02-04T04:59:59Z", "2019-12-05T16:16:42Z", "2019-26234", 0, 0, "09000064841e74ee"], ["FDA-2019-E-1061-0004", "FDA", "FDA-2019-E-1061", "Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEXXA", "Notice", "Determinations", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-06-03T03:59:59Z", "2019-12-05T16:00:10Z", "2019-26251", 0, 0, "09000064841e85d8"], ["FDA-2019-E-1060-0005", "FDA", "FDA-2019-E-1060", "Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEXXA", "Notice", "Determinations", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-06-03T03:59:59Z", "2019-12-05T15:58:19Z", "2019-26251", 0, 0, "09000064841e85d7"], ["FDA-2018-E-2596-0004", "FDA", "FDA-2018-E-2596", "Determination of Regulatory Review Period for Purposes of Patent Extension; LUXTURNA", "Notice", "Determinations", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-06-03T03:59:59Z", "2019-12-05T14:47:45Z", "2019-26252", 0, 0, "09000064841e7408"], ["FDA-2018-N-3179-0002", "FDA", "FDA-2018-N-3179", "Request for Nominations on Public Advisory Panels of the Medical Devices Advisory Committee", "Notice", "Advisory Committee", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-01-07T04:59:59Z", "2020-01-07T02:01:26Z", "2019-26276", 0, 0, "09000064841e7410"], ["FDA-2019-N-5464-0001", "FDA", "FDA-2019-N-5464", "Novel Excipient Review Program Proposal; Request for Information and Comments", "Notice", "60 Day Proposed Information Collection", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-02-04T04:59:59Z", "2020-02-04T02:01:22Z", "2019-26266", 0, 0, "09000064841e74ea"], ["FDA-2019-D-4656-0001", "FDA", "FDA-2019-D-4656", "Interstitial Cystitis/Bladder Pain Syndrome: Establishing Effectiveness of Drugs for Treatment; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-02-04T04:59:59Z", "2020-02-04T02:03:52Z", "2019-26264", 0, 0, "09000064841e7409"], ["FDA-2013-N-1619-0013", "FDA", "FDA-2013-N-1619", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "60 Day Proposed Information Collection", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-02-04T04:59:59Z", "2023-04-10T19:29:26Z", "2019-26250", 0, 0, "09000064841e74e6"], ["FDA-2018-N-3207-0002", "FDA", "FDA-2018-N-3207", "Request for Nominations of Voting Members on a Public Advisory Committee; National Mammography Quality Assurance Advisory Committee", "Notice", "Request for Nominations", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-02-04T04:59:59Z", "2019-12-05T15:42:10Z", "2019-26279", 0, 0, "09000064841e7452"], ["FDA-2019-E-1059-0004", "FDA", "FDA-2019-E-1059", "Determination of Regulatory Review Period for Purposes of Patent Extension; ANDEXXA", "Notice", "Determinations", "2019-12-05T05:00:00Z", 2019, 12, "2019-12-05T05:00:00Z", "2020-06-03T03:59:59Z", "2019-12-05T15:56:38Z", "2019-26251", 0, 0, "09000064841e7454"], ["FDA-2019-N-5119-0001", "FDA", "FDA-2019-N-5119", "Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Request for Comments", "2019-12-04T05:00:00Z", 2019, 12, "2019-12-04T05:00:00Z", "2019-12-17T04:59:59Z", "2019-12-17T02:04:01Z", "2019-26222", 0, 0, "09000064841e25a1"], ["FDA-2018-E-4403-0005", "FDA", "FDA-2018-E-4403", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; AIMOVIG", "Notice", "Determinations", "2019-12-03T05:00:00Z", 2019, 12, "2019-12-03T05:00:00Z", "2020-02-04T04:59:59Z", "2020-02-03T02:00:48Z", "2019-26081", 0, 0, "09000064841dda28"], ["FDA-2019-N-5120-0001", "FDA", "FDA-2019-N-5120", "Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Meeting", "2019-12-03T05:00:00Z", 2019, 12, "2019-12-03T05:00:00Z", "2019-12-18T04:59:59Z", "2019-12-18T02:01:19Z", "2019-26143", 0, 0, "09000064841ddac9"], ["FDA-2019-N-4590-0001", "FDA", "FDA-2019-N-4590", "Morton Grove Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 21\nAbbreviated New Drug Applications", "Notice", "Withdrawal", "2019-12-02T05:00:00Z", 2019, 12, "2019-12-02T05:00:00Z", null, "2020-05-04T17:35:53Z", "2019-25946", 0, 0, "09000064841d66e7"], ["FDA-2018-D-3124-0025", "FDA", "FDA-2018-D-3124", "Adaptive Designs for Clinical Trials of Drugs and Biologics; Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2019-12-02T05:00:00Z", 2019, 12, "2019-12-02T05:00:00Z", "2020-01-03T04:59:59Z", "2020-05-04T17:31:30Z", "2019-25986", 0, 0, "09000064841d6538"], ["FDA-2016-N-3995-0004", "FDA", "FDA-2016-N-3995", "Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Information on Pediatric Uses of Medical Devices", "Notice", "60 Day Proposed Information Collection", "2019-12-02T05:00:00Z", 2019, 12, "2019-12-02T05:00:00Z", "2020-02-01T04:59:59Z", "2019-12-04T02:03:29Z", "2019-25980", 0, 0, "09000064841d66ea"], ["FDA-2019-N-1537-0002", "FDA", "FDA-2019-N-1537", "James R. Casey: Final Debarment Order", "Notice", "Statutory Debarment", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", null, "2019-11-29T19:11:09Z", "2019-25848", 0, 0, "09000064841c8e8e"], ["FDA-2019-N-0163-0003", "FDA", "FDA-2019-N-0163", "Hospira, Inc., et al.; Withdrawal of Approval of Six Abbreviated New Drug Applications", "Notice", "Withdrawal", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", null, "2019-11-29T19:16:15Z", "2019-25901", 0, 0, "09000064841c88a9"], ["FDA-2019-D-5255-0002", "FDA", "FDA-2019-D-5255", "Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", "2020-01-29T04:59:59Z", "2020-01-29T02:08:15Z", "2019-25919", 0, 0, "09000064841c88a5"], ["FDA-2019-N-1614-0002", "FDA", "FDA-2019-N-1614", "Tzvi Lexier: Final Debarment Order", "Notice", "Statutory Debarment", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", null, "2019-11-29T19:18:11Z", "2019-25824", 0, 0, "09000064841c8d3b"], ["FDA-2018-E-2595-0004", "FDA", "FDA-2018-E-2595", "Determination of Regulatory Review Period for Purposes of Patent Extension; OZEMPIC", "Notice", "Determinations", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", "2020-05-28T03:59:59Z", "2019-11-29T19:13:51Z", "2019-25850", 0, 0, "09000064841c881f"], ["FDA-2018-E-4429-0005", "FDA", "FDA-2018-E-4429", "Determination of Regulatory Review Period for Purposes of Patent Extension; CRYSVITA", "Notice", "Determinations", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", "2020-05-28T03:59:59Z", "2020-05-25T01:00:37Z", "2019-25821", 0, 0, "09000064841c881c"], ["FDA-2013-N-0879-0008", "FDA", "FDA-2013-N-0879", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the\nSafe and Sanitary Processing and Importing of Fish and Fishery Products", "Notice", "30 Day Proposed Information Collection", "2019-11-29T05:00:00Z", 2019, 11, "2019-11-29T05:00:00Z", "2019-12-31T04:59:59Z", "2019-11-29T19:17:35Z", "2019-25857", 0, 0, "09000064841c8d34"], ["FDA-2019-D-5324-0001", "FDA", "FDA-2019-D-5324", "Compliance Policy for Limited Modifications to Certain Marketed Tobacco Products; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-11-26T05:00:00Z", 2019, 11, "2019-11-26T05:00:00Z", null, "2019-11-26T14:19:02Z", "2019-25578", 0, 0, "09000064841b7724"], ["FDA-2019-N-5465-0001", "FDA", "FDA-2019-N-5465", "Center for Devices and Radiological Health Ethylene Oxide Sterilization Master File Pilot Program", "Notice", "Request for Applications", "2019-11-26T05:00:00Z", 2019, 11, "2019-11-26T05:00:00Z", null, "2019-11-26T14:14:33Z", "2019-25631", 0, 0, "09000064841b75be"], ["FDA-2019-D-3592-0001", "FDA", "FDA-2019-D-3592", "Certificates of Confidentiality; Draft Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff; Availability", "Notice", "Notice of Availability", "2019-11-25T05:00:00Z", 2019, 11, "2019-11-25T05:00:00Z", "2020-01-10T04:59:59Z", "2020-01-09T02:03:06Z", "2019-25551", 0, 0, "09000064841ac63b"], ["FDA-2016-N-2066-0004", "FDA", "FDA-2016-N-2066", "Agency Information Collection Activities; Proposed Collection; Comment Request; Certification of Identity for Freedom of Information Act and Privacy Act Requests", "Notice", "60 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2019-11-24T02:02:33Z", "2019-25364", 0, 0, "0900006484197fea"], ["FDA-2011-N-0776-0014", "FDA", "FDA-2011-N-0776", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:48:10Z", "2019-07467", 0, 0, "0900006483bad8bb"], ["FDA-2007-D-0369-0476", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2020-02-28T02:02:42Z", "2019-25326", 0, 0, "0900006484197f8c"], ["FDA-2012-N-0129-0014", "FDA", "FDA-2012-N-0129", "Agency Information Collection Activities; Proposed Additional Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants", "Notice", "60 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2019-11-22T14:28:29Z", "2019-25328", 0, 0, "0900006484197e92"], ["FDA-2019-N-4844-0001", "FDA", "FDA-2019-N-4844", "\u2018\u2018Ruby Chocolate\u2019\u2019 Deviating From Identity Standard; Temporary Permit\nfor Market Testing", "Notice", "Notice of Temporary Permit", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:58:37Z", "2019-25325", 0, 0, "0900006484197fe7"], ["FDA-2018-N-2970-0003", "FDA", "FDA-2018-N-2970", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:41:39Z", "2019-07467", 0, 0, "0900006483bad4cc"], ["FDA-2017-N-1779-0008", "FDA", "FDA-2017-N-1779", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:43:14Z", "2019-07467", 0, 0, "0900006483bad4cd"], ["FDA-2018-N-3728-0005", "FDA", "FDA-2018-N-3728", "Agency Information Collection Activities; Proposed Collection; Comment Request; Collection of Information for Participation in the Food and Drug Administration Non- Employee Fellowship and Traineeship Programs", "Notice", "60 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2023-02-14T15:03:49Z", "2019-25332", 0, 0, "0900006484197fee"], ["FDA-2009-D-0268-0020", "FDA", "FDA-2009-D-0268", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:46:20Z", "2019-07467", 0, 0, "0900006483bad8b9"], ["FDA-2010-D-0319-0029", "FDA", "FDA-2010-D-0319", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Dear Health Care Provider Letters: Improving Communication of Important Safety Information", "Notice", "30 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2019-12-24T04:59:59Z", "2019-12-25T02:01:39Z", "2019-25333", 0, 0, "0900006484198033"], ["FDA-2016-N-0736-0005", "FDA", "FDA-2016-N-0736", "Agency Information Collection Activities; Proposed Collection; Comment Request; Tracking Network for PETNet, LivestockNet, and SampleNet", "Notice", "60 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2020-01-22T04:59:59Z", "2019-11-24T02:01:32Z", "2019-25327", 0, 0, "0900006484197f45"], ["FDA-2012-N-0129-0015", "FDA", "FDA-2012-N-0129", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:45:10Z", "2019-07467", 0, 0, "0900006483bad4d0"], ["FDA-2014-D-0609-0030", "FDA", "FDA-2014-D-0609", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:47:20Z", "2019-07467", 0, 0, "0900006483bad8ba"], ["FDA-2012-N-0197-0006", "FDA", "FDA-2012-N-0197", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Shortages Data Collection System", "Notice", "30 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2019-12-24T04:59:59Z", "2019-11-24T02:02:46Z", "2019-25368", 0, 0, "0900006484197eec"], ["FDA-2008-N-0500-0010", "FDA", "FDA-2008-N-0500", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:44:23Z", "2019-07467", 0, 0, "0900006483bad4cf"], ["FDA-2018-N-1967-0003", "FDA", "FDA-2018-N-1967", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approvals", "Notice", "Notice of Approval", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", null, "2019-11-22T16:40:30Z", "2019-07467", 0, 0, "0900006483bad4c7"], ["FDA-2013-N-1147-0007", "FDA", "FDA-2013-N-1147", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition", "Notice", "30 Day Proposed Information Collection", "2019-11-22T05:00:00Z", 2019, 11, "2019-11-22T05:00:00Z", "2019-12-24T04:59:59Z", "2022-10-21T19:21:41Z", "2019-25370", 0, 0, "0900006484197df6"], ["FDA-2019-D-4447-0001", "FDA", "FDA-2019-D-4447", "Transdermal and Topical Delivery Systems\u2014Product Development and\nQuality Considerations; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-11-21T05:00:00Z", 2019, 11, "2019-11-21T05:00:00Z", "2020-02-20T04:59:59Z", "2020-02-21T02:02:24Z", "2019-25246", 0, 0, "090000648418f9ef"], ["FDA-2018-N-3442-0089", "FDA", "FDA-2018-N-3442", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Web-Based Pilot Survey To Assess Allergy to Cosmetics in the United States", "Notice", "30 Day Proposed Information Collection", "2019-11-21T05:00:00Z", 2019, 11, "2019-11-21T05:00:00Z", "2019-12-24T04:59:59Z", "2019-11-24T02:01:41Z", "2019-25274", 0, 0, "090000648418fb2c"], ["FDA-2019-N-5035-0001", "FDA", "FDA-2019-N-5035", "Anesthetic and Analgesic Drug Products Advisory Committee; Notice\nof Meeting; Establishment of a Public Docket; Request for Comments", "Notice", "Request for Comments", "2019-11-21T05:00:00Z", 2019, 11, "2019-11-21T05:00:00Z", "2020-01-16T04:59:59Z", "2020-01-15T02:01:35Z", "2019-25278", 0, 0, "090000648418fa34"], ["FDA-2019-N-4963-0001", "FDA", "FDA-2019-N-4963", "Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of\nMeeting; Establishment of a Public Docket; Request for Comments", "Notice", "Request for Comments", "2019-11-21T05:00:00Z", 2019, 11, "2019-11-21T05:00:00Z", "2019-12-14T04:59:59Z", "2019-12-15T02:01:07Z", "2019-25247", 0, 0, "090000648418fb7f"], ["FDA-2018-D-4533-0001", "FDA", "FDA-2018-D-4533", "Compounding Animal Drugs From Bulk Drug Substances; Draft Guidance\nfor Industry; Availability", "Notice", "Notice of Availability", "2019-11-20T05:00:00Z", 2019, 11, "2019-11-20T05:00:00Z", "2020-02-19T04:59:59Z", "2020-10-13T19:32:07Z", "2019-25139", 0, 0, "090000648418566d"], ["FDA-2018-N-4626-0001", "FDA", "FDA-2018-N-4626", "List of Bulk Drug Substances for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations", "Notice", "Request for Nominations", "2019-11-20T05:00:00Z", 2019, 11, "2019-11-20T05:00:00Z", null, "2026-01-24T11:51:45Z", "2019-25140", 1, 0, "090000648418571f"], ["FDA-2019-N-4187-0029", "FDA", "FDA-2019-N-4187", "A New Era of Smarter Food Safety; Extension of Comment Period", "Notice", "Extension of Comment Period", "2019-11-20T05:00:00Z", 2019, 11, "2019-11-20T05:00:00Z", "2019-12-06T04:59:59Z", "2019-12-13T18:03:12Z", "2019-25123", 0, 0, "090000648418571d"], ["FDA-2019-N-5157-0001", "FDA", "FDA-2019-N-5157", "2019 Public Meeting on Center for Drug Evaluation and Research Standard Core Sets: Clinical Outcome Assessments and Endpoints Grant Program; Public Meeting; Request for Comments", "Notice", "Public Meetings", "2019-11-20T05:00:00Z", 2019, 11, "2019-11-20T05:00:00Z", "2020-03-07T04:59:59Z", "2020-03-07T02:02:10Z", "2019-25160", 0, 0, "0900006484185668"], ["FDA-2019-N-4693-0001", "FDA", "FDA-2019-N-4693", "Mayne Pharma Group Limited and Actavis Laboratories UT, Inc.; Withdrawal of Approval of Abbreviated New Drug Applications for Fentanyl Transdermal Systems", "Notice", "Withdrawal", "2019-11-18T05:00:00Z", 2019, 11, "2019-11-18T05:00:00Z", null, "2019-11-18T14:23:03Z", "2019-24922", 0, 0, "09000064841714e0"], ["FDA-2019-N-4992-0001", "FDA", "FDA-2019-N-4992", "Pan American Laboratories, LLC, et al.; Proposal To Withdraw Approval of Four New Drug Applications; Opportunity for a Hearing", "Notice", "Notice of Opportunity of Hearing", "2019-11-18T05:00:00Z", 2019, 11, "2019-11-18T05:00:00Z", "2020-01-18T04:59:59Z", "2019-11-18T14:18:41Z", "2019-24921", 0, 0, "09000064841714db"], ["FDA-2018-D-1835-0009", "FDA", "FDA-2018-D-1835", "Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2019-11-18T05:00:00Z", 2019, 11, "2019-11-18T05:00:00Z", null, "2019-11-18T14:07:39Z", "2019-24916", 0, 0, "09000064841713b7"], ["FDA-2019-N-2649-0001", "FDA", "FDA-2019-N-2649", "Advisory Committee; Nonprescription Drugs Advisory Committee, Renewal", "Notice", "Notice of Renewal", "2019-11-18T05:00:00Z", 2019, 11, "2019-11-18T05:00:00Z", null, "2019-11-18T14:14:57Z", "2019-24917", 0, 0, "0900006484171498"], ["FDA-2016-N-2544-0005", "FDA", "FDA-2016-N-2544", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Current Good Manufacturing Practice Quality System Regulation", "Notice", "30 Day Proposed Information Collection", "2019-11-15T05:00:00Z", 2019, 11, "2019-11-15T05:00:00Z", "2019-12-17T04:59:59Z", "2019-11-21T02:03:45Z", "2019-24805", 0, 0, "0900006484161302"]], "truncated": false, "filtered_table_rows_count": 799, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2019"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019", "results": [{"value": "FDA", "label": "FDA", "count": 799, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2019", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019", "results": [{"value": "Notice", "label": "Notice", "count": 799, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2019", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019", "results": [{"value": 2019, "label": 2019, "count": 799, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_facet_date=last_modified"}], "next": "2019-11-15T05~3A00~3A00Z,FDA-2016-N-2544-0005", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2019&_next=2019-11-15T05~3A00~3A00Z%2CFDA-2016-N-2544-0005&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1104.9665880855173, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}